A Proposal to End the COVID-19 Pandemic

Urgent steps are needed to arrest the rising human toll and economic strain from the COVID-19 pandemic that are exacerbating already-diverging recoveries. Pandemic policy is also economic policy as there is no durable end to the economic crisis without an end to the health crisis. Building on existi...

Full description

Bibliographic Details
Main Author: Agarwal, Ruchir
Other Authors: Gopinath, Gita
Format: eBook
Language:Italian
Published: Washington, D.C. International Monetary Fund 2021
Online Access:
Collection: International Monetary Fund - Collection details see MPG.ReNa
LEADER 02397nmm a2200241 u 4500
001 EB002082064
003 EBX01000000000000001222154
005 00000000000000.0
007 cr|||||||||||||||||||||
008 220928 ||| ita
020 |a 9781513593678 
100 1 |a Agarwal, Ruchir 
130 0 |a A Proposal to End the COVID-19 Pandemic 
245 0 0 |a A Proposal to End the COVID-19 Pandemic  |c Ruchir Agarwal, Gita Gopinath 
260 |a Washington, D.C.  |b International Monetary Fund  |c 2021 
300 |a 53 pages 
700 1 |a Gopinath, Gita 
041 0 7 |a ita  |2 ISO 639-2 
989 |b IMF  |a International Monetary Fund 
028 5 0 |a 10.5089/9781513593678.006 
856 4 0 |u http://elibrary.imf.org/view/journals/006/2021/004/006.2021.issue-004-it.xml  |x Verlag  |3 Volltext 
082 0 |a 330 
520 |a Urgent steps are needed to arrest the rising human toll and economic strain from the COVID-19 pandemic that are exacerbating already-diverging recoveries. Pandemic policy is also economic policy as there is no durable end to the economic crisis without an end to the health crisis. Building on existing initiatives, this paper proposes pragmatic actions at the national and multilateral level to expeditiously defeat the pandemic. The proposal targets: (1) vaccinating at least 40 percent of the population in all countries by the end of 2021 and at least 60 percent by the first half of 2022, (2) tracking and insuring against downside risks, and (3) ensuring widespread testing and tracing, maintaining adequate stocks of therapeutics, and enforcing public health measures in places where vaccine coverage is low. The benefits of such measures at about USD 9 trillion far outweigh the costs which are estimated to be around USD 50 billion-of which USD 35 billion should be paid by grants from donors and the residual by national governments potentially with the support of concessional financing from bilateral and multilateral agencies. The grant funding gap identified by the Access to COVID-19 Tools (ACT) Accelerator amounts to about USD 22 billion, which the G20 recognizes as important to address. This leaves an estimated USD 13 billion in additional grant contributions needed to finance our proposal. Importantly, the strategy requires global cooperation to secure upfront financing, upfront vaccine donations, and at-risk investment to insure against downside risks for the world